Basis of Presentation and Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Schedule of Revenue Disaggregated by Product and Service Type

The following table shows revenue disaggregated by product and service type for the three months ended March 31, 2023 and 2022 (in thousands):

	Three Months Ended March 31,
	2023		2022
Scilex Pharmaceuticals Inc. product sales	$	10,582	$	6,812
Sorrento Therapeutics, Inc. product revenues		15		3,178
Net product revenues	$	10,597	$	9,990
Concortis Biosystems Corporation	$	3,007	$	4,634
Bioserv Corporation		671		875
Other service revenues		1,976		2,886
Service revenues	$	5,654	$	8,395